Access cutting-edge glaucoma treatment through this clinical trial at a research site in Petaluma. Study-provided care at no cost to qualified participants.
Access glaucoma specialists in Petaluma at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glaucoma treatment provided free
This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonstrate bioequivalence with clinical endpoint in subjects with chronic open-angle glaucoma or ocular hypertension in both eyes. Test Product - Bimatoprost ophthalmic solution, 0.01% of Amneal EU, Limited Reference Product - LUMIGAN® (bimatoprost ophthalmic solution) 0.01% of Allergan, Inc.
Sponsor: Amneal Pharmaceuticals, LLC
Check if you qualify for this glaucoma clinical trial in Petaluma, CA
If you're searching for glaucoma treatment options in Petaluma, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Petaluma research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glaucoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.